Details

Autor(en) / Beteiligte

• Bleu, Melusine
• Mermet-Meillon, Fanny
• Apfel, Verena
• Barys, Louise
• Holzer, Laura
• Bachmann Salvy, Marianne
• Lopes, Rui
• Amorim Monteiro Barbosa, Inês
• Delmas, Cecile
• Hinniger, Alexandra
• Chau, Suzanne
• Kaufmann, Markus
• Haenni, Simon
• Berneiser, Karolin
• Wahle, Maria
• Moravec, Ivana
• Vissières, Alexandra
• Poetsch, Tania
• Ahrné, Erik
• Carte, Nathalie
• Voshol, Johannes
• Bechter, Elisabeth
• Hamon, Jacques
• Meyerhofer, Marco
• Erdmann, Dirk
• Fischer, Matteo
• Stachyra, Therese
• Freuler, Felix
• Gutmann, Sascha
• Fernández, César
• Schmelzle, Tobias
• Naumann, Ulrike
• Roma, Guglielmo
• Lawrenson, Kate
• Nieto-Oberhuber, Cristina
• Cobos-Correa, Amanda
• Ferretti, Stephane
• Schübeler, Dirk
• Galli, Giorgio Giacomo

Titel

PAX8 and MECOM are interaction partners driving ovarian cancer

Ist Teil von

• Nature communications, 2021-04, Vol.12 (1), p.2442-2442, Article 2442

Ort / Verlag

London: Nature Publishing Group UK

Erscheinungsjahr

2021

Quelle

Electronic Journals Library

Beschreibungen/Notizen

• The transcription factor PAX8 is critical for the development of the thyroid and urogenital system. Comprehensive genomic screens furthermore indicate an additional oncogenic role for PAX8 in renal and ovarian cancers. While a plethora of PAX8-regulated genes in different contexts have been proposed, we still lack a mechanistic understanding of how PAX8 engages molecular complexes to drive disease-relevant oncogenic transcriptional programs. Here we show that protein isoforms originating from the MECOM locus form a complex with PAX8. These include MDS1-EVI1 (also called PRDM3) for which we map its interaction with PAX8 in vitro and in vivo. We show that PAX8 binds a large number of genomic sites and forms transcriptional hubs. At a subset of these, PAX8 together with PRDM3 regulates a specific gene expression module involved in adhesion and extracellular matrix. This gene module correlates with PAX8 and MECOM expression in large scale profiling of cell lines, patient-derived xenografts (PDXs) and clinical cases and stratifies gynecological cancer cases with worse prognosis. PRDM3 is amplified in ovarian cancers and we show that the MECOM locus and PAX8 sustain in vivo tumor growth, further supporting that the identified function of the MECOM locus underlies PAX8-driven oncogenic functions in ovarian cancer. Lineage-restricted transcription factor PAX8 is oncogenic in ovarian cancer cells. Here the authors show that PAX8 interacts and recruits a splice variant of the MECOM locus PRDM3 to control the gene expression module involved in adhesion and extracellular matrix, and consequently promotes ovarian tumorigenesis.